image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Forterra

March 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • FORT
  • Price:
  • 252p
Brick maker Forterra announced that strong trading continued until the year-end, in line with expectations. Encouragingly, 2022 is “continuing where 2021 ended,” helped by significant double digit selling prices across key products in late ’21 / January 2022. That offset significant cost increases including energy, albeit 70% of 2022 energy requirements are now secured with greatest coverage in the key winter months. Encouragingly, the brick factory expansion projects are progressing in line with the timetable and budget and will increase production capacity by 16% in Q4 ’22 when Desford comes on line  while commissioning for Wilnecote is expected Q2 ’23. Cash generation remains strong with net cash rising to £40m and managem ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X